Evidence map›Paper›PMID 38412618›Full record

ArticleACS synthetic biology2024

Engineering

Collin R Barnum, Myeong-Je Cho, Kasey Markel, Patrick M Shih

Open access · hybridAbstract read
In one paragraph

Article in ACS synthetic biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Glucosinolates inInternational journal of molecular sciences · 2026
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Collin R BarnumDepartment of Plant and Microbial Biology, University of California, Berkeley, Berkeley, California 94270, United States.
Myeong-Je ChoInnovative Genomics Institute, University of California, Berkeley, Berkeley, California 94720, United States.ORCID 0000-0002-7638-7235
Kasey MarkelDepartment of Plant and Microbial Biology, University of California, Berkeley, Berkeley, California 94270, United States.ORCID 0000-0002-8285-3888
Patrick M ShihDepartment of Plant and Microbial Biology, University of California, Berkeley, Berkeley, California 94270, United States.ORCID 0000-0002-2119-3345
Lawrence Berkeley National Laboratory · USInnovative Genomics Institute · USUniversity of California, Davis · US

Funding

Developing plant synthetic biology platforms to elucidate the role of natural productsR00AT009573 · NCCIH · UNIVERSITY OF CALIFORNIA BERKELEY · PI SHIH, PATRICK · 2018 to 2020
$704k
NCCIH NIH HHS R00 AT009573
6 · The paper itself

Abstract

Glucosinolates are plant-specialized metabolites that can be hydrolyzed by glycosyl hydrolases, called myrosinases, creating a variety of hydrolysis products that benefit human health. While cruciferous vegetables are a rich source of glucosinolates, they are often cooked before consumption, limiting the conversion of glucosinolates to hydrolysis products due to the denaturation of myrosinases. Here we screen a panel of glycosyl hydrolases for high thermostability and engineer the

Indexed as

BrassicaCookingCrops, AgriculturalGlucosinolatesGlycoside HydrolasesHumansIsothiocyanatesGlucosinolatesGlycoside HydrolasesIsothiocyanatesenzyme thermostabilityglucosinolatemyrosinaseplant synthetic biology

Identifiers

PMID38412618
PMCPMC10949231
OpenAlexW4392185216

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.